Drug interactions
Budesonide-formoterol + Encorafenib
Severity: Moderate
Budesonide-formoterol and Encorafenib: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Encorafenib can prolong the QT interval in a dose-dependent manner, and formoterol has been associated with QT prolongation and arrhythmias at higher exposures. Combined use may increase the risk of torsades de pointes, particularly with electrolyte disturbance.
What this interaction means in plain words
Budesonide-formoterol and Encorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Budesonide-formoterol belongs to Respiratory; Encorafenib belongs to Oncology.
Why it happens
Additive QT prolongation through different pharmacodynamic mechanisms.
What to do
Obtain a baseline ECG and monitor ECG periodically during use. Correct potassium and magnesium before and during treatment.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Budesonide-formoterol and Encorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Budesonide-formoterol
Other interactions of Encorafenib
Frequently asked questions
Can I take Budesonide-formoterol with Encorafenib?
MediHelp rates the interaction as moderate. Budesonide-formoterol and Encorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Encorafenib can prolong the QT interval in a dose-dependent manner, and formoterol has been associated with QT prolongation and arrhythmias at higher exposures. Combined use may increase the risk of torsades de pointes, particularly with electrolyte disturbance.
How serious is the interaction between Budesonide-formoterol and Encorafenib?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor ECG periodically during use. Correct potassium and magnesium before and during treatment.
What other medicines interact with Budesonide-formoterol?
MediHelp also lists interactions of Budesonide-formoterol with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Budesonide-formoterol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
